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Cerebral malaria is the most deadly manifestation of infection
with Plasmodium falciparum. The pathology of cerebral malaria is
characterized by the accumulation of infected erythrocytes (IEs) in
the microvasculature of the brain caused by parasite adhesins on
the surface of IEs binding to human receptors on microvascular
endothelial cells. The parasite and host molecules involved in this
interaction are unknown. We selected three P. falciparum strains
(HB3, 3D7, and IT/FCR3) for binding to a human brain endothelial
cell line (HBEC-5i). The whole transcriptome of isogenic pairs of
selected and unselected parasites was analyzed using a variant
surface antigen-supplemented microarray chip. After selection,
the most highly and consistently up-regulated genes were a subset
of group A-like var genes (HB3var3, 3D7_PFD0020c, ITvar7, and
ITvar19) that showed 11- to >100-fold increased transcription lev-
els. These var genes encode P. falciparum erythrocyte membrane
protein (PfEMP)1 variants with distinct N-terminal domain types
(domain cassette 8 or domain cassette 13). Antibodies to HB3var3
and PFD0020c recognized the surface of live IEs and blocked bind-
ing to HBEC-5i, thereby conﬁrming the adhesive function of these
variants. The clinical in vivo relevance of the HBEC-selected para-
sites was supported by signiﬁcantly higher surface recognition of
HBEC-selected parasites compared with unselected parasites by
antibodies from young African children suffering cerebral malaria
(Mann–Whitney test, P = 0.029) but not by antibodies from controls
with uncomplicated malaria (Mann–Whitney test, P = 0.58). This
work describes a binding phenotype for virulence-associated group
A P. falciparum erythrocyte membrane protein 1 variants and iden-
tiﬁes targets for interventions to treat or prevent cerebral malaria.
adherence | pathogenesis | sequestration
Cerebral malaria (CM) is the most serious outcome of a Plas-modium falciparum infection, leading to death in 10–20% of
cases and to long-term neurological deﬁcits in others (1). The
hallmark of the disease is microvascular sequestration, a process
in which P. falciparum–infected erythrocytes (IEs) cytoadhere to
endothelial cells, leading to microvascular obstruction, acidosis,
hypoxia, and release of inﬂammatory cytokines (reviewed in ref.
2). Currently there is no speciﬁc treatment for CM other than
standard antimalarial drugs and supportive therapies such as ﬂuid
replacement (3). The molecular mechanisms underlying CM are
not understood, partly because of the lack of an appropriate an-
imal model (4). However, human brain microvascular endothelial
cell (HBEC) lines, such as HBEC-5i (5), can be used to study
malaria host–parasite interactions, providing an in vitro model for
CM (6–9). Despite the existence of this in vitro model, the par-
asite ligand(s) and host-cell receptor(s) mediating the interaction
between IEs and brain endothelial cells remain unknown.
Previous work has identiﬁed variant surface antigens (VSA)
such as P. falciparum erythrocyte membrane protein 1 (PfEMP1)
as the parasite ligands mediating adhesion to a variety of
receptors on human cells (10, 11). The PfEMP1 family is enco-
ded by 50–60 var genes per parasite isolate (12). Although the
sequence of each var gene is unique, all variants start with an N-
terminal segment (NTS) and are followed by a succession of
Duffy binding-like (DBL) and cysteine-rich interdomain region
(CIDR) domains. These domains can be categorized into sub-
types by the presence of short, conserved amino acid motifs, the
rest of the sequence being highly polymorphic (13). The var gene
family is subdivided into three main subgroups, A, B, and C,
based on semiconserved upstream sequences (12). All group A var
genes are located near the telomeres, all groupC var genes are near
the centromeres, and group B var genes can be found in either
location. The var gene groups have functional and clinical signiﬁ-
cance. Group B and C var genes encode PfEMP1 variants that bind
CD36 (14, 15) and are linked to nonvirulent clinical disease,
whereas group A var genes encode non–CD36-binding variants
linked to severe clinical disease including CM (16–19). Some group
A var genes encode PfEMP1 variants that bind to uninfected
erythrocytes to form rosettes (20–25); however, the adhesion phe-
notype of the majority of group A variants is unknown currently.
Although, because of their position on the surface of IEs,
PfEMP1 encoded by var genes and other VSA such as riﬁns and
stevors are the major candidates for parasite adhesion ligands, it
remains possible that other parasite adhesins remain to be dis-
covered. We investigated the whole transcriptome of parasites se-
lected for binding to HBEC-5i cells to identify the parasite ligands
for adhesion. We postulated that the parasite ligand(s) necessary
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for binding to HBEC-5i would be expressed at a higher level in
selected (adherent) than in unselected (nonadherent) parasites and
tested the hypothesis using microarray technology (25).
Results
Selection of P. falciparum for Binding to HBEC-5i. Preliminary
experiments indicated that in vitro cultures of P. falciparum ad-
here poorly to HBEC-5i (Fig. 1A, Left). Four P. falciparum
laboratory strains (HB3, 3D7, IT, and Dd2) were selected for
binding to HBEC-5i cells by repeated panning (9). After ﬁve
to seven rounds of selection, HBEC-5i–adherent lines were
obtained from the HB3 (Fig. 1A, Right), 3D7, and IT strains. The
P. falciparum strain Dd2 did not increase in adhesion to HBEC-5i
cells even after ﬁve rounds of selection, suggesting that Dd2 lacks
(or is unable to transcribe or transport) the necessary parasite
ligand or that the lack of knobs in Dd2 prevents adhesion (26).
HB3 was selected twice independently on HBEC-5i to provide
a replicate for subsequent experiments (HB3-HBEC1 and 2).
HB3 also was selected on TNF-activated HBEC-5i (HB3-HBEC-
TNF) to investigate whether different parasite ligands would be
selected on cytokine-stimulated and resting endothelial cells.
To assess the relevance of HBEC-5i selection for primary hu-
man tissues, HB3-HBEC parasites were tested for adhesion to
primary endothelial cells derived from brain, dermal, and lung
tissues (ScienCell). In all cases the selected parasites showed en-
hanced binding to primary endothelial cells (>10-fold greater
adhesion of selected than unselected parasites) (Fig. 1B). Fur-
thermore, HBEC-5i–binding IEs that were physically detached
fromHBEC-5i cells and then incubated with other endothelial cell
lines showed strong binding (Fig. 1C), excluding the possibility that
subpopulations of parasites bound to the different cell lines. These
data show that the HBEC-5i–selected phenotype is relevant for
primary human tissues and indicates that the host receptor is
present on endothelia from diverse sources, consistent with se-
questration of IEs in multiple endothelial beds in CM patients in
vivo (27). Neither unselected nor HB3-HBEC–selected parasite
lines bound above background levels to COS-7 cells, showing that
the selected parasites do not bind nonspeciﬁcally to all cell types.
Adhesion Phenotype of HBEC-5i–Selected Parasites. The other ad-
hesion properties of the selected parasites were examined. The
selected lines from all three strains did not form rosettes (SI
Appendix, Fig. S1A), and platelet-mediated clumping was reduced
signiﬁcantly after selection for HBEC-5i binding (SI Appendix,
Fig. S1B). HB3-HBEC–selected parasites showed signiﬁcantly
lower binding to CD36 and ICAM-1 than did HB3–unselected
parasites (SI Appendix, Fig. S1C), and there was no increase in
binding to any known P. falciparum adhesion receptor, including
fractalkine, PECAM-1, P-selectin, E-selectin, VCAM-1, integrin
αVβ3, thrombospondin, NCAM, ﬁbronectin, heparin, chondroi-
tin sulfate A, hyaluronic acid, gC1qR, or heparan sulfate (SI
Appendix, Fig. S1C and Table S1). IT-HBEC–selected parasites
also showed signiﬁcantly lower binding to CD36 than did IT–
unselected parasites, and the only minor but statistically signiﬁ-
cant increase was in binding to gC1qR (SI Appendix, Fig. S1D),
although absolute levels of binding remained low. gC1qR has
been implicated primarily as a platelet-mediated clumping re-
ceptor for P. falciparum, although it also is expressed on endo-
thelial cells (28). IT-HBEC parasites had a clumping frequency of
<2%; therefore it seems unlikely that gC1qR is a major receptor
for these parasites. Adhesion-blocking antibodies to CD36 (29)
and ICAM-1 (30) had no effect on binding of HBEC-selected
parasites to HBEC-5i (SI Appendix, Fig. S1E), thus further ex-
cluding a role for these receptors in HBEC-5i binding. Therefore
we were unable to identify the HBEC-5i receptor(s) used by the
HBEC-selected parasite lines, and HBEC-5i binding may involve
an unknown host endothelial receptor.
We also examined knob positivity in the selected and un-
selected parasite lines, because lack of knobs is known to in-
ﬂuence parasite adhesion properties (26). We found that the
percentage of knob-positive IEs in the selected and unselected
lines of each strain did not differ signiﬁcantly (mean percent of
knob-positive IE (SE) for HB3-HBEC–selected, 62.5 (2.3) and –
unselected, 65.0 (1.7), P = 0.41; IT-HBEC–selected, 69.3 (2.5)
and –unselected, 68.3 (2.7), P = 0.79; 3D7-HBEC–selected, 54.0
(1.5) and –unselected, 55.5 (1.7), P = 0.53; unpaired t test in
each case). Therefore, the presence or absence of knobs is un-
likely to explain the differences in HBEC-5i adhesion between
the selected and unselected parasite strains.
Whole-Transcriptome Analysis Identiﬁes a Subset of Group A var
Genes as Being Highly Transcribed in HBEC-5i–Selected Parasites.
We used a VSA-supplemented microarray chip to examine the
whole transcriptome of selected and unselected parasites, with
the aim of identifying candidate parasite adhesion ligands as
gene(s) whose transcriptional levels increased markedly after
selection (25). The VSA-supplemented chip contains oligonu-
cleotide probes for all the VSA genes (var, rif, and stevor) from
the HB3, IT, and Dd2 strains (25) added to the existing 3D7-
based chip (31). Isogenic pairs of selected and unselected P.
falciparum parasite cultures were synchronized (SI Appendix,
Table S2), and RNA samples were collected every 8 h for 48 h.
The selected and unselected parasites were at similar levels of
maturity during the time-course experiment, as shown by Giemsa
smear (SI Appendix, Fig. S2) and by strongly positive Pearson
A
B
C
Fig. 1. Selection of P. falciparum IEs for adhesion to HBMEC. (A) Unselected
P. falciparum lines (e.g., HB3 shown here) show only minimal binding to
HBEC-5i cells (Left). After ﬁve rounds of panning, adherent parasites are
selected (Right). The cells were ﬁxed with glutaraldehyde, stained with
Giemsa, and visualized by microscopy at 1,000×magniﬁcation. (B) Binding of
selected (HB3-HBEC) and unselected (HB3-Uns) parasite lines to primary
endothelial cells from human brain (HBMEC), skin (HDMEC), and lung
(HPMEC). Means + SE from triplicate wells are shown. (C) Rebinding of HBEC-
5i–adherent IEs that were detached mechanically from HBEC-5i cells and
then reincubated with HBEC-5i cells (positive control), HDMEC, or HPMEC.
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correlation coefﬁcients when data from all oligonucleotide
probes at each time point for selected and unselected parasites
were compared (SI Appendix, Fig. S3; see exceptions for time
point 3 of HB3-HBEC-TNF and time point 6 of IT-HBEC,
whose data should be interpreted with caution).
The level of transcription of each gene in selected parasites was
compared with that in unselected parasites and was expressed as
a fold expression ratio. In HB3, the gene with the most markedly
and consistently increased transcription in selected parasites was
a group A var gene, HB3var3 (Fig. 2 A–D andG). There were ﬁve
oligonucleotide probes on the microarray chip for this gene, and
all ﬁve showed strongly increased hybridization signals in HB3-
HBEC1 and HB3-HBEC2 compared with unselected HB3 (Fig. 2
B and C). Taking an average of all ﬁve probes, HB3var3 was up-
regulated in selected parasites by up to 61-fold (Fig. 2G). (By
“up-regulated” we mean that the amount of mRNA for a partic-
ular gene was increased in selected compared with unselected
parasites.) Selection of HB3 parasites on TNF-activated HBEC-
5i also resulted in a parasite population with increased tran-
scription of HB3var3 (Fig. 2 D and G). Multiple other var genes
were up-regulated at time point 3 in the parasites selected on
TNF-activated HBEC-5i, but the upregulation of these genes may
have been caused by poor synchronization between selected and
unselected parasites at this time point (SI Appendix, Fig. S3).
In 3D7, a single group A var gene, PFD0020c, showed the most
marked and consistent increase in transcription after selection
(Fig. 2 E and G). All six oligonucleotide probes to PFD0020c
showed a similar pattern. In the IT strain, two var genes, ITvar7
(group A) and ITvar19 (group B), showed highly increased
transcription after selection (Fig. 2F). The ﬁve probes speciﬁc to
each of these two genes showed, on average, an up-regulation of
10- to more than 100-fold (Fig. 2G).
When the ﬁve selections are considered together, the micro-
array data for the var gene family are striking. In all ﬁve selec-
tions, one or two var genes show markedly increased transcription
in the selected parasites, but multiple other var genes are down-
regulated. At time point 3 (16–24 h postinvasion), there is an 11-
to 320-fold increase in HB3var3, PFD0020C, ITvar9, and ITvar19
in the selected populations (Fig. 2G). No other var gene was up-
regulated by more than twofold across more than one time point.
Quantitative real-time PCR (qPCR) with speciﬁc primers to the
var genes of each parasite strain conﬁrmed the up-regulation
detected by microarray (Fig. 2G) and did not detect any other up-
regulated var genes. Expression proﬁling by RT-PCR with uni-
versal primers to the var gene DBLα region (32, 33) also identiﬁed
the same set of up-regulated var genes (SI Appendix, Fig. S4 A–D),
conﬁrming that all three methods are comparable. RT-PCR
experiments on HB3 parasites selected for binding to human
dermal microvascular endothelial cells (HDMEC) and human
pulmonary microvascular endothelial cells (HPMEC) showed that
the group A var gene up-regulated with HBEC-5i (HB3var3) also
was up-regulated following selection on other endothelial types
(SI Appendix, Fig. S4E).
Rif Genes Located Head-to-Head with the var Gene Ligand Candidates
Are Up-Regulated. In the rif family, three genes showed increased
transcription by threefold or more in at least one time point in all
three HB3 selections (Fig. 3A). Only one of these genes,
HB3RifA_081, showed a substantial, eight- to 100-fold increase
(Fig. 3B). Interestingly, this rif gene is located next to HB3var3,
on the opposite strand, and is transcribed in the opposite di-
rection. Thus, the selection of HB3 parasites on HBEC-5i, with
or without prior activation with TNF, led to the increased tran-
scription of HB3var3 and its “head-to-head” HB3_RifA_081
gene. No stevor gene was up-regulated by threefold or more in all
three HB3-derived selections.
In 3D7-HBEC, the most highly up-regulated rif gene was
PFD0025w (Fig. 3B and SI Appendix, Fig. S5A). Again, this rif
gene is located head-to-head with the most highly transcribed var
gene, PFD0020c. Several other rif genes and four stevor genes
showed more than threefold up-regulation in at least one time
point (SI Appendix, Fig. S5A). These data are each based on
a single probe (because of the small size of rif and stevor genes)
and a single experiment; therefore further replicates would be
required to determine whether these increases are consistent. In
IT-HBEC, ﬁve rif genes and one stevor gene showed more than
threefold up-regulation in a single time point (SI Appendix, Fig
S5B). No expression data were available for IT4rifA_044, the rif
gene found head to head with ITvar7. This lack of data may
mean that this gene is not transcribed above background levels in
one of the parasite populations or could be the result of a tech-
nical problem, such as misprinting of the oligonucleotide probe.
The other up-regulated var gene in IT parasites, ITvar19, does
not have a head-to-head rif gene, because these head-to-head
arrangements are found only with group A var genes.
To conﬁrm the up-regulation of the speciﬁc head-to-head rif
genes in the HB3 and 3D7 strains, and to examine further the
transcription of IT4rifA_044, the rif gene found head-to-head
with ITvar7, we carried out real-time qPCR with rif-speciﬁc
primers (34). This evaluation conﬁrmed the up-regulation of
HB3_RifA_081 in HB3-selected parasites and PFD0025w in 3D7-
selected parasites (Fig. 3B). Furthermore, the data showed a 446-
fold increase in IT4rifA_044 in IT-selected parasites (Fig. 3B).
Taken together, these data indicate that selection for binding
to HBEC-5i leads to increased transcription of speciﬁc group A
var genes and that the rif genes located head-to-head with
these var genes are up-regulated also. Therefore, the genes
HB3rifA_081, PFD0025w, and IT4rifA_044 also should be con-
sidered as encoding potential parasite ligands for HBEC-5i bind-
ing, given the known location of riﬁns on the surface of IEs (35).
Some Exported Proteins Show Increased Transcription in HBEC-
Selected Parasites. The four var genes identiﬁed above and their
accompanying rif genes are by far the most highly and consistently
up-regulated genes after selection. However, other non-VSA
genes could be involved in cytoadherence to HBEC-5i. The vast
majority of non-VSA genes have a sequence that is virtually
identical from one strain to another; therefore the three strains
(HB3, 3D7, and IT) can be considered as replicates of each other
(36). Using the arbitrary cutoff of a twofold increase in at least one
time point, 15 non-VSA genes were found to be up-regulated, and
58 non-VSA genes were down-regulated in all ﬁve selections (SI
Appendix, Figs. S6 and S7). No speciﬁc functional pathways were
statistically signiﬁcantly up-regulated by functional enrichment
analysis. Furthermore, no non-VSA genes showed increases in
transcription comparable in intensity or consistency to the up-
regulated var genes (SI Appendix, Fig. S6 and Fig. 2). Only one
gene was up-regulated by at least threefold in all ﬁve selections:
PF14_0472, a member of the Plasmodium helical interspersed
subtelomeric (PHISTa) family (37). Six other up-regulated genes
encode proteins predicted or proven to be exported: P. falciparum
erythrocyte membrane protein 3 (PfEMP3) (38), ring-IE surface
antigen (RESA-1) (39), membrane associated histine-rich pro-
tein 1 (MAHRP-1) (40), and three others with a Pexel motif:
PF14_0740, PF11_0035, and PFF0055w (37). These six genes and
PF14_0472 are up-regulated at time point 3 (16–24 h postinvasion)
in almost all selections, indicating that they could be translated in
time for cytoadherence at the pigmented trophozoite stage.
Of the 58 down-regulated genes, 11 were down-regulated by at
least threefold in at least one time point (SI Appendix, Fig. S7).
Intriguingly, 41 of the 58 down-regulated genes encode proteins
proven or predicted to be involved with merozoite invasion. In-
deed, a functional enrichment analysis revealed the merozoite
invasion pathway to be highly enriched (P ∼0) (SI Appendix,
Table S3). In other words, the selection of parasites for binding
to HBEC-5i resulted in a statistically highly signiﬁcant decrease
E1774 | www.pnas.org/cgi/doi/10.1073/pnas.1120461109 Claessens et al.
in transcription of invasion-related genes. This decrease in
transcription occurred during time points 1–5 but not at time
point 6 (schizogony) when invasion genes primarily are expected
to be transcribed and translated. Thus, the actual amounts of
invasion proteins necessary for merozoites to invade red blood
cells may remain the same in HBEC-5i–selected parasites.
A B
F
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D E
G
Fig. 2. Microarray analysis indicates that a subset of group A var genes shows markedly increased transcription after selection for HBEC-5i binding. (A) Color
scale showing the fold expression ratios of gene transcription in selected versus unselected parasites. (B–F) Var gene transcription throughout the 48 h asexual
life cycle in HBEC-5i–selected and unselected P. falciparum strains HB3: (B) replicate 1, HB3-HBEC1; (C) replicate 2, HB3-HBEC2; (D) HB3 on TNF-stimulated
cells;,HB3-HBEC-TNF; (E) 3D7-HBEC; and (F) IT-HBEC. Each row represents a different oligonucleotide probe, and each column is a time point. T1 = maximum
parasite maturity, 8 h postinvasion; T2 = 16 h; T3 = 24 h; T4 = 32 h; T5 = 40 h; T6 = 48 h. Red rectangles indicate higher transcription in the selected than in the
unselected population. Green rectangles indicate higher transcription in the unselected population. A gray rectangle indicates no var gene transcription
detected above background level in at least one parasite population. For each selection, the most highly up-regulated var gene(s) has been zoomed out. All
oligonucleotide probes are shown except for those with no transcription above background level at any time point. A few var genes have sections of se-
quence identical to other var genes within the same strain (62). For example, the second half of HB3var3 shows similarities with HB3var5 and HB3var46p.
Therefore, some oligos are not unique to a single sequence. *1, oligos HB3var46p_2 and HB3var46p_3 match the HB3var3 gene. Oligos HB3var46p_0 and
HB3var46p_1 are unique to HB3var46p and are not up-regulated. *2, oligos HB3var5_2 and HB3var5_3 match HB3var3. Oligos HB3var5_0 and HB3var5_1 are
unique to HB3var5 and are not up-regulated. *3, oligos ITvar32_2, ITvar32_3, and *4, oligo ITvar6_0 - match ITvar19. However, other oligos speciﬁc to ITvar32
(ITvar32_0 and 1) and ITvar6 (ITvar6_1, 2 and 3) are not up-regulated. (G) Expression fold ratios (unlogged) of the most up-regulated var genes in each
selection. Numbers represent the average of all oligonucleotide probes speciﬁc to that gene. The last column indicates real-time qPCR data obtained from
RNA at late ring stage. NA, not available (i.e., no transcription above background level was detected in at least one parasite population); ND, not determined.
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Taken together, examination of the entire transcriptome of
three P. falciparum strains selected for adhesion to HBEC-5i
identiﬁes a subset of group A var genes and their head-to-head rif
genes as the most likely candidates for adhesion ligands because
of their markedly increased transcription after selection.
Up-Regulated Var Genes Show Similarities in PfEMP1 Architecture.
Examination of the var genes up-regulated in HBEC-5i–selected
parasites reveals that they encode PfEMP1 variants that are di-
verse in sequence (32–46% amino acid identity between each
pair) (SI Appendix, Table S4). However, the up-regulated var-
iants do show similarities in PfEMP1 architecture (Fig. 4). As
expected for group A var genes, HB3var3, PFD0020c, and ITvar7,
all encode variants with a DBLα1 domain at the N-terminus,
whereas the group B ITvar19 variant has a DBLα2 domain (Fig.
4). Despite its group B upstream region, the ITvar19-encoded
variant has some group A-like features: It is large (with seven
extracellular domains, compared with four for a typical group B
variant) and has a CIDRα1 domain (usually found in group A
variants). The presence of the CIDRα1 domain, which is un-
common (present in <10% of all var genes) is the most obvious
distinguishing feature of the four adhesion ligand candidates.
DBLα1 and CIDRα1 domains recently have been classiﬁed into
subgroups on the basis of sequence homology (41). Both
HB3var3 and ITvar7 have the N-terminal domain pair DBLα1.7/
CIDR1α1.4, also known as “domain cassette (DC) 13.” [Domain
cassettes are sets of PfEMP1 domains that usually occur together
(41).] Of seven P. falciparum strains whose var gene repertoires
have been fully sequenced and classiﬁed, most strains have only
one variant with DC13, and these variants are all group A var
genes that show PfEMP1 architecture similar to that of HB3var3
and ITvar7 (41). Thus, DC13-type variants, including HB3var3
and ITvar7, may represent functionally similar alleles in different
parasite strains. PFD0020c and ITvar19 have different DBLα
types, but they share very similar CIDRα1.1 domains with 74%
amino acid identity (but only 39–43% identity with CIDRα1.4 of
HB3var3 and ITvar7) (SI Appendix, Table S4). Other sequenced
strains usually have only one variant with a CIDRα1.1 domain,
and most of these strains are group B PfEMP1 variants with
PfEMP1 architecture similar to that in ITvar19, represented by
DC8 (41). PFD0020c has three of the four domains usually found
in DC8, differing only in the ﬁrst DBL domain (Fig. 4).
The HB3var3 variant is identical to HB3var5 from the DBLγ
domain to the end of the extracellular region. The fact that
HB3var3 but not HB3var5 was up-regulated after selection for
binding to HBEC-5i suggests that the functional binding region
includes the ﬁrst three domains (NTS-DBLα-CIDRα-DBLβ)
that differ in HB3var3 and HB3var5.
Antibodies Against HB3var3 Inhibit Adhesion of HB3-HBEC to HBEC-5i.
The transcriptional patterns shown above combined with the
known adhesion properties of PfEMP1 make the PfEMP1 var-
iants encoded by HB3var3, PFD0020c, ITvar7, and ITvar19 the
most likely candidate parasite adhesion ligands for HBEC-5i
binding. To test the hypothesis that this subset of group A-like
var genes encodes the parasite ligands for adhesion to HBEC-5i,
we raised antibodies to speciﬁc PfEMP1 domains.
The NTS-DBLα1 and the NTS-DBLα1-CIDRα1 (hereafter
called the “di-domain”) from HB3var3 were expressed as
recombinant proteins in Escherichia coli. For NTS-DBLα1, the
recombinant protein was mostly of the expected molecular
weight (54.1 kDa) and showed a shift upon reduction, indicating
the presence of disulﬁde bonds in the recombinant protein (Fig.
5A, Left). For the di-domain, much of the protein was degraded,
although some protein at the expected molecular weight (88.2
Fig. 3. The rif genes located head-to-head with the up-regulated var genes
are up-regulated also. (A) HB3 rif genes up-regulated by at least threefold in
all HB3-derived strains. Because of the small size of rif genes (1–2 kbp), there
was only one oligonucleotide probe per gene on the microarray chip. Color
scale is as in Fig. 2. (B) Expression fold ratios of the rif genes located head-to-
head with the most up-regulated var genes in each selection. The last col-
umn indicates real-time qPCR data, obtained from RNA at late ring stage.
NA, not available (i.e., no transcription above background level was detec-
ted in at least one parasite population); ND, not determined.
TM
var gene 
name
HB3var3          A1
Upstream
sequence
   DBLα1.7  CIDRα1.4 DBLγ12          DBLδ5           ATSNT
S DBLβ3    CIDRβ3    DBLβ7    NT
S
TM
TM
DC13
ITvar7    A1 DBLα1.7
 CIDRα1.4 DBLγ10           NT
S DBLβ1    NT
S DBLβ3    DBLδ1 CIDRβ1    ATS
TM
DC13
3D7 PFD0020c A1 DBLα1.2
 CIDRα1.1NT
S DBLβ12    NT
S DBLγ11           DBLδ1 CIDRγ6    DBLγ6           ATS
DC8
ATSDBLα2
 CIDRα1.1 DBLγ6          DBLδ1           DBLβ12    CIDRβ1    NT
S DBLγ9           ITvar19   B1
DC8
Fig. 4. PfEMP1 architecture of variants up-regulated after HBEC-5i selection. ATS, acidic terminal segment; CIDR, cysteine-rich interdomain region; DBL,
Duffy binding-like domain; DC13, domain cassette 13; DC8, domain cassette 8; NTS, N-terminal segment. Pairwise amino acid identities between domains are
shown in SI Appendix, Tables S4 and S5.
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kDa), and which showed a shift upon reduction, was obtained
(Fig. 5A, Right).
Antisera to HB3var3 NTS-DBLα1 and the di-domain showed
punctate surface ﬂuorescence of live HB3-HBEC IEs by immu-
noﬂuorescence assay (IFA) (Fig. 5B) typical of PfEMP1 anti-
bodies (23). Rabbit preimmune sera and nonimmunized rabbit
control sera were negative by IFA. Total IgG were puriﬁed from
the antiserum and used at fourfold dilutions in ﬂow cytometry to
determine the end titer (here deﬁned as the lowest concentration
of total IgG to stain in >50% of live IEs). The HB3var3 NTS-
DBLα1 antibodies gave surface reactivity down to 0.39 μg/mL of
total IgG (Fig. 5C), and the di-domain antibodies gave surface
reactivity down to 1.56 μg/mL of total IgG. The HB3var3 NTS-
DBLα1 antibodies were tested at 400 μg/mL for live IE surface
reactivity with other P. falciparum strains selected for a range of
different adhesion phenotypes (24). The antibodies did not show
surface reactivity with HB3-unselected parasites, 3D7-HBEC,
3D7-unselected, IT-HBEC, IT-unselected, six P. falciparum
rosetting strains, or 12 clinical isolates (data are shown in ﬁgures
4b and 6a of ref. 24, in which the non-Ros group A control is
HB3var3 NTS-DBLα1 antibody). Therefore, the HB3var3 NTS-
DBLα1 antibodies are highly variant- and strain-speciﬁc and
show surface reactivity only with the homologous parasite line
HB3-HBEC expressing the HB3var3 PfEMP1 variant.
To determine whether the HB3var3 PfEMP1 variant is the
parasite ligand for binding to HBEC-5i, the effect of HB3var3
antibodies on adhesion was examined. Both NTS-DBLα1 and di-
domain antibodies inhibited binding to HBEC-5i compared with
control nonimmunized rabbit IgG (Fig. 5D). Polyclonal rabbit IgG
raised against a PfEMP1 variant not involved in HBEC-binding
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Fig. 5. Antibodies against HB3var3 inhibit adhesion of HB3-HBEC to HBEC-5i cells. (A) SDS/PAGE showing recombinant NTS-DBLα1 and di-domain (NTS-
DBLα1-CIDRα1) domains from HB3var3 expressed in E. coli. (B) Immunoﬂuorescence assay with antisera to HB3var3 (1/100 dilution) showing punctate surface
ﬂuorescence on live IEs. IEs are shown by DAPI staining of the parasite nuclei. PfEMP1 antibody was detected with highly cross-absorbed goat anti-rabbit IgG
Alexa Fluor 488 (1/1,000). (C) Titration of anti-HB3var3 antibodies (puriﬁed total IgG) against live HB3-HBEC IEs by ﬂow cytometry. (D) Inhibition of HB3-HBEC
binding to HBEC-5i cells by antibodies to HB3var3 NTS-DBLα1 and di-domain. Means and SD from quadruplicate wells of a representative experiment are
shown. Binding is compared with control wells with no added IgG. Negative controls are nonimmunized rabbit IgG and IgG raised to the NTS-DBLα1 domain
of a rosette-mediating group A PfEMP1 variant (HB3var6). A signiﬁcant decrease in adhesion was seen in the presence of HB3var3 antibodies (P < 0.0001,
ANOVA). ***P < 0.001, *P < 0.05, Tukey’s multiple comparison test. (E) Inhibition of HB3-HBEC binding to HBEC-5i cells by antibodies to HB3var3 DBLδ5. Mean
and SE from three independent experiments are shown. Binding is compared with control wells with no added IgG. The negative control is preimmune serum
from the rabbit used to raise DBLδ5 antibodies. A signiﬁcant decrease in adhesion was seen in the presence of HB3var3 antibodies (P < 0.0001, ANOVA).
*P < 0.05, ***P < 0.001, Tukey’s multiple comparison test.
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(against the NTS-DBLα1 domain of the rosette-mediating
HB3var6 group A PfEMP1 variant) (24) showed no inhibition of
binding (Fig. 5D). We also tested antiserum raised against another
recombinant domain of the HB3var3 variant (DBLδ5) produced
in baculovirus (42). Previous work has shown that antibodies to
multiple PfEMP1 domains are able to block adhesion in the case
of rosetting parasites (23). The HB3var3 DBLδ5 antiserum
showed punctate surface ﬂuorescence with live IEs of HB3-HBEC
parasites at 1/25 and 1/100 dilution, whereas the preimmune se-
rum was negative at the same concentrations. The antiserum was
negative by IFA against HB3-unselected, 3D7-HBEC, 3D7-un-
selected, IT-HBEC, and IT-unselected parasites. The antiserum
to HB3var3 DBLδ5 showed speciﬁc inhibition of adhesion of
HB3-HBEC IEs to HBEC-5i, although it was not as effective as
NTS-DBLα1 antibody (Fig. 5E). Therefore, three different anti-
body preparations against two distinct domains of the HB3var3
PfEMP1 variant inhibited binding of HB3-HBEC to HBEC5i,
conﬁrming that HB3var3 is a parasite adhesion ligand and making
it extremely unlikely that antibody cross-reactivity with other
molecules on the surface of IEs is responsible for the data shown.
None of the antibodies caused agglutination of IEs at the con-
centrations used in the adhesion inhibition assays.
Antibodies to two distinct domains of the PfEMP1 variant up-
regulated in 3D7 parasites, PFD0020c, also were tested for ad-
hesion inhibition. Antibodies to the NTS-DBLα1 domain of
PFD0020c (produced in E. coli) gave punctate surface ﬂuores-
cence of 3D7-HBEC live IEs down to 6.25 μg/mL of total IgG,
whereas antibodies to DBLγ6 (produced in Baculovirus) gave
surface reactivity down to 100 μg/mL Both antibodies were
variant- and strain-speciﬁc and did not show surface reactivity
with the IT- or HB3-HBEC–selected or –unselected parasite lines
when tested at 400 μg/mL The NTS-DBLα1 antibodies inhibited
binding of 3D7-HBEC to HBEC-5i by 52% compared with rabbit
IgG control at 50 μg/mL of total IgG, whereas the DBLγ6 anti-
bodies inhibited binding by 64% compared with rabbit IgG con-
trol at 250 μg/mL of total IgG (P< 0.001, paired t test). Therefore,
for PFD0020c, two independent antibody preparations to sepa-
rate domains show variant- and strain-speciﬁc surface reactivity
and inhibit adhesion of 3D7-HBEC to HBEC-5i, providing
evidence that the PFD0020c PfEMP1 variant is the parasite
adhesion ligand.
In Vivo Signiﬁcance of the HBEC-5i–Binding Subset of Group A PfEMP1
Variants. No animal model adequately reﬂects the pathology and
clinical features of severe P. falciparum malaria in humans;
therefore, it is not possible to test directly whether HBEC-5i–se-
lected parasites cause CM. As an alternative approach to examine
the in vivo signiﬁcance of the HBEC-5i–binding variants, we in-
vestigated whether African children suffering from CM develop
antibodies that recognize the HBEC-selected parasite lines.
Plasma samples from acutely ill or convalescent Kenyan children
with CM or uncomplicated malaria (UM) were used to assess
surface recognition of live IEs from selected and unselected par-
asites by ﬂow cytometry. Acute plasma samples collected from
both clinical groups at the time of hospital admission (pre-
dominantly reﬂecting prior exposure) showed no signiﬁcant dif-
ference in their reactivity with selected or unselected parasite lines
(Fig. 6 A and B). However, plasma samples from convalescent
patients with CM (reﬂecting antibody responses to the variant
causing the clinical episode) showed signiﬁcantly greater recog-
nition of the HBEC-selected lines than of the unselected lines
(Fig. 6C). In contrast, plasma samples from convalescent patients
with UM did not show differential reactivity with HBEC-selected
lines compared with -unselected lines (Fig. 6D), although surface
reactivity against both HBEC-selected and -unselected lines in-
creased compared with the samples from acutely ill patients (Fig. 6
B and D). When each parasite strain was considered individually,
all three strains showed a trend toward increased recognition of
HBEC-selected compared with -unselected parasites in sera from
convalescent patients with CM, but the increase was statistically
signiﬁcant only in the 3D7 strain (SI Appendix, Fig. S8).
Discussion
In this work we found that a distinct subset of groupA-like var genes
was highly transcribed in three P. falciparum strains selected for
adhesion to an HBEC line (Fig. 2). The up-regulated genes encode
PfEMP1 variants with similar domain structures exempliﬁed by the
presence of DC8 (3D7_PFD0020c and ITvar19) or DC13 (HB3var3
and ITvar7) (Fig. 4). In their companion articles, Avril et al. (43)
provide independent conﬁrmation of the up-regulation of DC8
genes following selection on brain endothelial cells, and Lavstsen
et al. (44) show DC8 and DC13 genes to be highly differentially
transcribed in patients with severe malaria compared with UM
controls, conﬁrming the clinical importance of DC8- and DC13-
expressing parasites. DC8 genes were differentially transcribed in
all clinical forms of severe malaria (CM, severe malarial anemia,
and respiratory distress), consistent with our ﬁndings and those of
Avril et al. (43) that parasites selected for binding to HBEC-5i
also could adhere to other primary endothelial cell types, giving
the potential to sequester at multiple sites throughout the body in
addition to the brain. Taken together, these three studies identify
parasites expressing DC8 and DC13 as having high potential for
cytoadherence to endothelial cells in the brain and elsewhere and
A B
C D
Fig. 6. Recognition of HBEC-selected and -unselected parasites lines by
antibodies from African malaria patients. Acute and convalescent plasma
samples were collected from 10 patients with CM and 10 age- and date of
admission-matched patients with UM. Surface recognition of HBEC-selected
and -unselected (uns) parasite lines was tested by ﬂow cytometry. The mean
ﬂuorescence intensity (MFI) of the uninfected erythrocyte population was
subtracted from the MFI of the IE population to give the speciﬁc MFI of the
IE population shown on the y axis. Each data point represents plasma from
one patient. The median of the values from the three individual strains was
used to represent the speciﬁc recognition of HBEC-selected or -unselected
parasites by each plasma sample (the individual strains are shown in SI Ap-
pendix, Fig. S8). (A) Acute plasma from patients with CM. (B) Acute plasma
from patients with UM. (C) Convalescent plasma from patients with CM. (D)
Convalescent plasma from patients with UM. IQR, interquartile range.
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suggest that DC8 and DC13 PfEMP1 variants may be important
targets for interventions to treat or prevent severe malaria.
To conﬁrm the role of DC8 and DC13 PfEMP1 variants in
binding to HBEC-5i, we raised antibodies to domains of
HB3var3 and 3D7_PFD0020. In each case antibodies to two
distinct domains showed variant- and strain-speciﬁc reactivity
with the surface of live IEs and blocked binding of IEs to HBEC-
5i (Fig. 5). These data strongly support the identiﬁcation of the
HB3var3 and PFD0020c PfEMP1 variants as parasite adhesion
ligands for HBEC-5i binding.
Our examination of the whole transcriptome of three parasite
strains showed that the only other highly up-regulated genes
after selection for HBEC-5i binding were the rif genes located
head-to-head with the up-regulated group A var genes (Fig. 3).
Given the known location of riﬁns on the surface of IEs (35), it is
possible that the riﬁns could contribute to host cell binding;
further experiments will be required to test this possibility. An
alternative hypothesis is that the rif genes are up-regulated be-
cause their transcriptional pattern is linked to the adjacent head-
to-head var gene. The coregulation of group A var genes and
their adjacent rif genes has been reported previously (34, 45) and
also was seen in our proof-of-concept experiment for the VSA-
supplemented microarray with rosetting parasites (25).
The microarray approach has the potential to reveal non-VSA
genes that could be involved directly or indirectly in cytoadher-
ence, for example by contributing to the trafﬁcking of PfEMP1 to
the IE surface. We found only 15 non-VSA genes that were up-
regulated by twofold or more in all selections; among these genes
were several encoding proteins predicted to be exported into the
infected red blood cell cytoplasm (SI Appendix, Fig. S6). Two of
these genes, MAHRP-1 and PF14_0752 (PHISTa), also were
modestly up-regulated in IT parasites selected for rosetting (25).
An indirect role for MAHRP-1 in cytoadherence already had
been demonstrated, because deletion of the gene leads to de-
pletion of surface-exposed PfEMP1 (46). PF14_0752 is part of
the PHISTa subfamily, whose members are speciﬁc to P. falci-
parum (37). PF14_0752 was one of the most highly up-regulated
genes in CD36-selected parasites (47), in ﬁeld isolates (48), and
in 3D7 gametocytes (49). Recently a PHISTc family member was
shown to bind to the intracellular domain of PfEMP1 (50);
however the function of other PHIST family members is un-
known and awaits further research.
One of the attractions of the microarray approach is its potential
to reveal previously unrecognized parasite adhesion proteins. At
ﬁrst sight, to conclude that the major adhesion ligands are PfEMP1
variants, with a possible contribution from riﬁns, could be consid-
ered disappointing. Similarly, our previous microarray study of
rosetting parasites conﬁrmed the marked transcriptional up-
regulation of the known parasite rosetting ligand, the PfEMP1
variant encoded by ITvar9 (20), and did not identify any strong
alternative candidates (25). However, we suggest that these data,
rather than being disappointing, are important precisely because
they provide a convincing demonstration of the importance of
PfEMP1 in parasite adhesion that is based on global transcriptional
data rather than relying solely on the examination of individual
genes and gene families that has characterized previous work.
The demonstration here of up-regulation of a subset of group
A-like var genes in HBEC-5i–selected parasites ﬁts well with
a body of previous work on var gene transcription in P. falcipa-
rum clinical isolates as well as the companion article by Lavstsen
et al. (44). The majority of studies addressing the relationship
between var genes and clinical disease have found an association
between group A var gene transcription and severe malaria or
CM (16–19, 51). Previously, the only known binding phenotype
for group A PfEMP1 variants was rosetting (20–23), with two
group A domain cassettes (DC11 and DC16) being linked to
rosette formation (24). DC16 was not associated with severe
malaria in the study by Lavstsen et al. (44) and DC11 was not
tested. DC11 is linked to IgM-positive rosetting (24), which
probably is the most clinically important rosetting phenotype
(52). Further research will be required to study the association
between DC11 variants and severe malaria.
ICAM-1 often is cited as an endothelial receptor involved in
CM (53); however, its precise role remains uncertain, because
several studies show no signiﬁcant increase in ICAM-1 binding in
parasite isolates from patients with CM as compared with con-
trols (54–56). Furthermore, a human ICAM-1 polymorphism
that occurs at high frequency in Africa (57) and reduces the
ability of P. falciparum to bind to ICAM-1 (53, 58) does not
protect against CM or severe malaria (59). In the work shown
here, although ICAM-1 is expressed on the surface of HBEC-5i,
it is not the receptor used by the HBEC-selected parasites be-
cause (i) in spot-binding assays HBEC-selected parasites did not
show increased binding to recombinant ICAM-1 compared with
-unselected parasites (SI Appendix, Fig. S1 C and D); (ii) ICAM-
1 antibodies did not block adhesion of selected parasites to
HBEC-5i (SI Appendix, Fig S1E); and (iii) IT-HBEC parasites
express ITvar7 and ITvar19, which have been shown to be ICAM-
1 nonbinders (60). The endothelial receptor(s) used by the
HBEC-5i–selected parasites are currently unknown.
In conclusion, we show that the P. falciparum ligands for ad-
hesion to HBEC-5i are a subset of group A-like PfEMP1 variants
(DC8 and DC13 type). The clinical relevance of these variants
was shown by recognition of HBEC-selected lines by sera from
children recovering from CM, thus validating the interaction
with HBEC-5i as an in vitro model for CM sequestration. The
DC8 and DC13 PfEMP1 variants represent potential targets for
interventions to prevent or treat CM.
Materials and Methods
Please see SI Appendix, Text for the materials and methods related to the
adhesion properties of selected and unselected parasite lines; microarray
hybridizations; real-time qPCR; the generation of polyclonal antibodies to
HB3var3 NTS-DBLα1, HB3var3 di-domain, and 3D7 PFD0020c NTS-DBLα1; the
generation of polyclonal antibodies to HB3var3 DBLδ5 and 3D7 PFD0020c
DBLγ6; and ﬂow cytometry with plasma from African children.
Parasite and Human Endothelial Cell Culture. P. falciparum strains HB3, 3D7,
IT/FCR3, and Dd2 were cultured in supplemented RPMI medium as described
(61). The HBEC-5i cell line is an immortalized endothelial line described
previously (5). HBEC-5i cells were grown in DMEM/F-12 medium (Sigma)
supplemented with 2 mM L-glutamine, endothelial cell growth supplement
(5 mL of 100× per 500 mL of medium, hereafter referred as “incomplete
medium”) (ScienCell), and 10% vol/vol heat-inactivated bovine serum. Par-
asite strains were selected by panning as described in detail previously (9).
For HB3-HBEC-TNF, HBEC-5i cells were activated 24 h before selection by
addition of TNFα at 50 μg/mL. HBMEC, HDMEC, and HPMEC (all from Sci-
enCell) were cultured as for HBEC-5i cells, except for the use of endothelial
cell medium (ScienCell) and bovine serum at 5% vol/vol, following the
manufacturer’s instructions.
Binding Assays on Endothelial Cells. The day before the assay, endothelial cells
were platedonﬁbronectin-coated eight-well chamber slides (BioCoat 354628;
BD) at 104 cells per well. For each assay, at least two replicate wells per slide
were used. Parasite cultures were washed twice with incomplete medium.
Two hundred microliters of parasite culture (pigmented trophozoites at 5–
10% parasitemia and 2% hematocrit) in incomplete DMEM/1% BSA were
added per well. The slide was incubated for 75 min at 37 °C with gentle
resuspension of cells halfway through the incubation. The chamber then was
removed according to the manufacturer’s instructions. The slide was washed
in a 100-mm Petri dish (351029; BD) ﬁlled with incomplete DMEM. The slide
was held still using tweezers, and the dish was rocked gently. This step was
repeated four times, each time in a newdishwith freshmedium. The slidewas
checked under an inverted microscope to ensure there were no or few un-
bound cells remaining. It then was ﬁxed and stained with 1% glutaraldehyde
for at least 1 h and was stained with 5% vol/vol Giemsa for 20 min. IEs bound
to at least 100 isolated cells were counted by light microscopy using the 100×
objective. For rebinding assays, after the washing step, bound IEs were de-
tached by ﬂushing the cell surface with incomplete DMEM using a Pasteur
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pipette at least 10 times. IEs were placed in a 15-mL tube and centrifuged at
300 × g for 5min. They were resuspended with 200 μL of incomplete DMEM
per well and then were reincubated on endothelial cells as above.
IFA and Flow Cytometry with Antibodies to PfEMP1. IFA with rabbit pre-
immune and immune sera and live IEs were carried out as described (23). For
each antigen, the rabbit serum giving the brightest IFA signal with the lowest
background was chosen for puriﬁcation of total IgG. Staining for ﬂow
cytometry was carried out as for IFA except that all incubations included 1.25
μg/mL Hoechst (instead of DAPI) to stain parasite nuclei. After the secondary
incubation (1:1,000 of a highly cross-absorbed Alexa Fluor 488 goat anti-rabbit
IgG) (Invitrogen) andwashes, cells were ﬁxed in 0.5%paraformaldehyde on ice
for 20min andwashed twice in FACS buffer (PBS/0.1%BSA/0.1% sodiumazide).
Cells were resuspended in 500 μL of FACS buffer and analyzed on a Becton-
Dickinson LSRII ﬂow cytometer by counting 500,000 events.
Antibody Inhibition of Binding to HBEC-5i Cells. Binding assays were carried out
as described above, with a preincubation step in which the culture suspension
(5–10% parasitemia and 2% hematocrit in incomplete DMEM/1% BSA) was
incubated for 20 min with antibodies to PfEMP1 or controls (concentrations
are shown in ﬁgure legends). Two hundred microliters of this suspension
were added per well on the endothelial cell culture slide, and the assay was
completed as described above. Binding was compared with control wells
with no added IgG. All antibodies were tested in at least three independent
experiments with at least triplicate wells per antibody in each experiment.
Statistical Analysis. Graphs and statistical analysis were carried out using
GraphPad Prism software (GraphPad).
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